EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Network-Medicine-Guided Drug Repurposing for Alzheimer’s Disease: A Multi-Dimensional Systems Pharmacology Approach

Ömer Akgüller iD, Mehmet Ali Balcı iD, Gabriela Cioca iD

International Journal of Molecular Sciences · 14.10.2025 · 26 (20) · 10003

DOI: 10.3390/ijms262010003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.10.2025. Verfasst von Ömer Akgüller und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mathematics, Faculty of Science, Mugla Sitki Kocman University, Muğla 48000, Turkey. Hauptthemen laut MEDLINE: Drug Repositioning, Alzheimer Disease, Network Pharmacology. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) drug development faces persistent challenges from blood–brain barrier limitations and inadequate integration of medicinal chemistry considerations with computational predictions. We developed a comprehensive Central Nervous System (CNS)-focused network medicine framework integrating machine-learning-validated BBB penetration prediction (95.7% accuracy, 0.992 AUC-ROC), modality-specific tractability assessment, and transparent evidence classification to identify viable drug repurposing candidates. CNS-specific pre-filtering refined 24,474 DGIdb compounds to 8247 CNS-relevant drugs, analyzed through multi-dimensional network scoring and systematic pharmaceutical property assessment. Modality stratification generated separate rankings for small molecules (3667 candidates), peptides (73 candidates), and biologics (3 candidates), acknowledging distinct BBB penetration mechanisms. Analysis revealed 64.8% of small molecules achieving Class I (Highly Tractable) status, with 83.6% demonstrating favorable BBB penetration. Plerixafor emerged as the top-ranked small molecule (score: 1.170), while trofinetide achieved the highest peptide ranking (score: 1.387), though classified as speculative, pending AD-specific validation. Successful identification of the FDA-approved AD therapeutics memantine and donepezil among the top candidates validated the computational performance, while the predominance of mechanistic evidence classifications (86.7%) highlighted that network predictions represent hypothesis-generating tools requiring systematic experimental validation rather than definitive therapeutic recommendations. The framework bridges computational predictions with pharmaceutical development requirements, providing actionable prioritization for systematic preclinical investigation addressing AD intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug RepositioningAlzheimer DiseaseNetwork PharmacologyHumansBlood-Brain BarrierMachine Learning

Stichwörter der Autor:innen

Alzheimer’s diseasedrug repurposingnetwork medicinesystems pharmacology

Autor:innen und Institutionen

  • Department of Mathematics, Faculty of Science, Mugla Sitki Kocman University, Muğla 48000, Turkey.
  • Preclinical Department, Faculty of Medicine, Lucian Blaga University of Sibiu, 550024 Sibiu, Romania.

ORCID-Profile: Ömer Akgüller, Mehmet Ali Balcı, Gabriela Cioca

Zitieren

APA

Akgüller, Ö., Balcı, M. A., & Cioca, G. (2025). Network-Medicine-Guided Drug Repurposing for Alzheimer’s Disease: A Multi-Dimensional Systems Pharmacology Approach. International Journal of Molecular Sciences, 26(20), 10003. https://doi.org/10.3390/ijms262010003

Vancouver

Akgüller Ö, Balcı MA, Cioca G. Network-Medicine-Guided Drug Repurposing for Alzheimer’s Disease: A Multi-Dimensional Systems Pharmacology Approach. International Journal of Molecular Sciences. 2025;26(20):10003. doi:10.3390/ijms262010003

BibTeX
@article{Akgller2025,
  author = {Akgüller, Ömer and Balcı, Mehmet Ali and Cioca, Gabriela},
  title = {Network-Medicine-Guided Drug Repurposing for Alzheimer’s Disease: A Multi-Dimensional Systems Pharmacology Approach},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {20},
  pages = {10003},
  doi = {10.3390/ijms262010003}
}
Kostenlos starten →